These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Colorectal cancer AND PMS2, HNPCC4, 5395, ENSG00000122512, H_DJ0042M02_9, PMSL2, PMS2CL AND Clinical Outcome
52 results:

  • 1. clinical significance of Bacteroides fragilis as a potential prognostic factor in colorectal cancer.
    Matsumiya Y; Suenaga M; Ishikawa T; Kudo T; Nakagawa T; Okamoto K; Tokunaga M; Hurtado C; Yamada Y; Oka K; Takahashi M; Lopez Kostner LF; O'Ryan Gallardo ML; Uetake H; Kinugasa Y
    Anaerobe; 2023 Dec; 84():102784. PubMed ID: 37806638
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. Spatially resolved multimarker evaluation of CD274 (PD-L1)/PDCD1 (PD-1) immune checkpoint expression and macrophage polarisation in colorectal cancer.
    Elomaa H; Ahtiainen M; Väyrynen SA; Ogino S; Nowak JA; Lau MC; Helminen O; Wirta EV; Seppälä TT; Böhm J; Mecklin JP; Kuopio T; Väyrynen JP
    Br J Cancer; 2023 Jun; 128(11):2104-2115. PubMed ID: 37002343
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. [clinical outcome of Microsatellite Instability-High Patients Treated with Pembrolizumab and Genetic Counseling].
    Shimura S; Tsumura H; Araki N; Kawada R; Shimazu S; Waraya M; Yoshida T; Takada F; Iwamura M; Sasaki J
    Gan To Kagaku Ryoho; 2022 Oct; 49(10):1099-1104. PubMed ID: 36281602
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. Increased Co-Occurrence of Pathogenic Variants in Hereditary Breast and Ovarian cancer and Lynch Syndromes: A Consequence of Multigene Panel Genetic Testing?
    Infante M; Arranz-Ledo M; Lastra E; Abella LE; Ferreira R; Orozco M; Hernández L; Martínez N; Durán M
    Int J Mol Sci; 2022 Sep; 23(19):. PubMed ID: 36232793
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. ESR1, PGR, ERBB2, and MKi67 mRNA expression in postmenopausal women with hormone receptor-positive early breast cancer: results from ABCSG Trial 6.
    Filipits M; Rudas M; Singer CF; Fitzal F; Bago-Horvath Z; Greil R; Balic M; Lax SF; Halper S; Hulla W; Wu NC; Liu X; Weidler J; Bates M; Hlauschek D; Gnant M; Dubsky P
    ESMO Open; 2021 Aug; 6(4):100228. PubMed ID: 34371382
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. Association between apoptosis inhibitor of macrophage and microsatellite instability status in colorectal cancer.
    Huang WJ; Wang X; Zhang ML; Li L; Wang RT
    BMC Gastroenterol; 2020 Nov; 20(1):373. PubMed ID: 33172404
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. Effect of Exercise or Metformin on Biomarkers of Inflammation in Breast and colorectal cancer: A Randomized Trial.
    Brown JC; Zhang S; Ligibel JA; Irwin ML; Jones LW; Campbell N; Pollak MN; Sorrentino A; Cartmel B; Harrigan M; Tolaney SM; Winer EP; Ng K; Abrams TA; Sanft T; Douglas PS; Hu FB; Fuchs CS; Meyerhardt JA
    Cancer Prev Res (Phila); 2020 Dec; 13(12):1055-1062. PubMed ID: 32859615
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. Germline susceptibility variants impact clinical outcome and therapeutic strategies for stage III colorectal cancer.
    Lin PC; Yeh YM; Wu PY; Hsu KF; Chang JY; Shen MR
    Sci Rep; 2019 Mar; 9(1):3931. PubMed ID: 30850667
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. Two histologically colorectal carcinomas subsets from the serrated pathway show different methylome signatures and diagnostic biomarkers.
    García-Solano J; Turpin MC; Torres-Moreno D; Huertas-López F; Tuomisto A; Mäkinen MJ; Conesa A; Conesa-Zamora P
    Clin Epigenetics; 2018 Nov; 10(1):141. PubMed ID: 30413173
    [TBL] [Abstract] [Full Text] [Related]  

  • 10. DNA mismatch repair deficiency but not ARID1A loss is associated with prognosis in small intestinal adenocarcinoma.
    González I; Goyal B; Xia MD; Pai RK; Ma C
    Hum Pathol; 2019 Mar; 85():18-26. PubMed ID: 30381262
    [TBL] [Abstract] [Full Text] [Related]  

  • 11. Survival outcome and prognostic model of patients with colorectal cancer on phase 1 trials.
    Kam AE; Pendurti G; Shah UH; Ghalib MH; Chaudhary I; Chuy J; Rajdev L; Kaubisch A; Aparo S; Mantzaris I; Goel S
    Invest New Drugs; 2019 Jun; 37(3):490-497. PubMed ID: 30315379
    [TBL] [Abstract] [Full Text] [Related]  

  • 12. clinical Impact of Mismatch Repair Protein Testing on outcome of Early Staged colorectal Carcinomas.
    Gandhi JS; Goswami M; Sharma A; Tanwar P; Gupta G; Gupta N; Pasricha S; Mehta A; Singh S; Agarwal M; Gupta N
    J Gastrointest Cancer; 2018 Dec; 49(4):406-414. PubMed ID: 28585041
    [TBL] [Abstract] [Full Text] [Related]  

  • 13. Automated telephone communication systems for preventive healthcare and management of long-term conditions.
    Posadzki P; Mastellos N; Ryan R; Gunn LH; Felix LM; Pappas Y; Gagnon MP; Julious SA; Xiang L; Oldenburg B; Car J
    Cochrane Database Syst Rev; 2016 Dec; 12(12):CD009921. PubMed ID: 27960229
    [TBL] [Abstract] [Full Text] [Related]  

  • 14. clinical Significance of TLR1 I602S Polymorphism for Patients with Metastatic colorectal cancer Treated with FOLFIRI plus Bevacizumab.
    Okazaki S; Loupakis F; Stintzing S; Cao S; Zhang W; Yang D; Ning Y; Sunakawa Y; Stremitzer S; Matsusaka S; Berger MD; Parekh A; West JD; Miyamoto Y; Suenaga M; Schirripa M; Cremolini C; Falcone A; Heinemann V; DePaolo RW; Lenz HJ
    Mol Cancer Ther; 2016 Jul; 15(7):1740-5. PubMed ID: 27196764
    [TBL] [Abstract] [Full Text] [Related]  

  • 15. Biological and Prognostic Significance of the Morphological Types and Vascular Patterns in colorectal Liver Metastases (CRLM): Looking Beyond the Tumor Margin.
    Siriwardana PN; Luong TV; Watkins J; Turley H; Ghazaley M; Gatter K; Harris AL; Hochhauser D; Davidson BR
    Medicine (Baltimore); 2016 Feb; 95(8):e2924. PubMed ID: 26937938
    [TBL] [Abstract] [Full Text] [Related]  

  • 16. Potentially Important Extracolonic Findings at Screening CT Colonography: Incidence and outcomes Data From a clinical Screening Program.
    Pooler BD; Kim DH; Pickhardt PJ
    AJR Am J Roentgenol; 2016 Feb; 206(2):313-8. PubMed ID: 26491809
    [TBL] [Abstract] [Full Text] [Related]  

  • 17. Exposure and Tumor Fn14 Expression as Determinants of Pharmacodynamics of the Anti-TWEAK Monoclonal Antibody RG7212 in Patients with Fn14-Positive Solid Tumors.
    Meulendijks D; Lassen UN; Siu LL; Huitema AD; Karanikas V; Mau-Sorensen M; Jonker DJ; Hansen AR; Simcox ME; Schostack KJ; Bottino D; Zhong H; Roessler M; Vega-Harring SM; Jarutat T; Geho D; Wang K; DeMario M; Goss GD; Schellens JH
    Clin Cancer Res; 2016 Feb; 22(4):858-67. PubMed ID: 26446946
    [TBL] [Abstract] [Full Text] [Related]  

  • 18. Fusobacterium nucleatum in colorectal carcinoma tissue and patient prognosis.
    Mima K; Nishihara R; Qian ZR; Cao Y; Sukawa Y; Nowak JA; Yang J; Dou R; Masugi Y; Song M; Kostic AD; Giannakis M; Bullman S; Milner DA; Baba H; Giovannucci EL; Garraway LA; Freeman GJ; Dranoff G; Garrett WS; Huttenhower C; Meyerson M; Meyerhardt JA; Chan AT; Fuchs CS; Ogino S
    Gut; 2016 Dec; 65(12):1973-1980. PubMed ID: 26311717
    [TBL] [Abstract] [Full Text] [Related]  

  • 19. Comparison of clinical outcome between laparoscopic and open right hemicolectomy: a nationwide study.
    Lee CZ; Kao LT; Lin HC; Wei PL
    World J Surg Oncol; 2015 Aug; 13():250. PubMed ID: 26271770
    [TBL] [Abstract] [Full Text] [Related]  

  • 20. Mismatch repair status may predict response to adjuvant chemotherapy in resectable pancreatic ductal adenocarcinoma.
    Riazy M; Kalloger SE; Sheffield BS; Peixoto RD; Li-Chang HH; Scudamore CH; Renouf DJ; Schaeffer DF
    Mod Pathol; 2015 Oct; 28(10):1383-9. PubMed ID: 26226846
    [TBL] [Abstract] [Full Text] [Related]  


    [Next]

    of 3.